Andy Chen

Stock Analyst at Wolfe Research

(4.48)
# 880
Out of 5,182 analysts
46
Total ratings
60%
Success rate
22.72%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Andy Chen

Palisade Bio
Apr 9, 2026
Initiates: Outperform
Price Target: $7
Current: $1.95
Upside: +258.97%
Avalo Therapeutics
Apr 9, 2026
Initiates: Outperform
Price Target: $48
Current: $12.86
Upside: +273.25%
Dianthus Therapeutics
Apr 9, 2026
Initiates: Outperform
Price Target: $98
Current: $83.67
Upside: +17.13%
Pharvaris
Apr 9, 2026
Initiates: Outperform
Price Target: $42
Current: $28.22
Upside: +48.83%
MoonLake Immunotherapeutics
Mar 23, 2026
Upgrades: Outperform
Price Target: $12$24
Current: $16.66
Upside: +44.06%
Vera Therapeutics
Mar 11, 2026
Upgrades: Outperform
Price Target: $88
Current: $37.11
Upside: +137.13%
Apogee Therapeutics
Jan 7, 2026
Initiates: Peer Perform
Price Target: n/a
Current: $85.37
Upside: -
Immunovant
Jan 6, 2026
Upgrades: Outperform
Price Target: $50
Current: $26.99
Upside: +85.25%
Kymera Therapeutics
Jan 6, 2026
Downgrades: Peer Perform
Price Target: n/a
Current: $83.85
Upside: -
Vertex Pharmaceuticals
Jan 6, 2026
Upgrades: Outperform
Price Target: $548
Current: $430.14
Upside: +27.40%
Downgrades: Peer Perform
Price Target: n/a
Current: $775.03
Upside: -
Downgrades: Peer Perform
Price Target: n/a
Current: $13.20
Upside: -
Initiates: Peer Perform
Price Target: n/a
Current: $40.99
Upside: -
Upgrades: Peer Perform
Price Target: n/a
Current: $302.11
Upside: -
Initiates: Outperform
Price Target: $49
Current: $69.71
Upside: -29.71%
Initiates: Peer Perform
Price Target: n/a
Current: $21.07
Upside: -
Initiates: Outperform
Price Target: n/a
Current: $66.11
Upside: -
Initiates: Peer Perform
Price Target: n/a
Current: $38.15
Upside: -
Initiates: Outperform
Price Target: $20
Current: $73.99
Upside: -72.97%
Initiates: Outperform
Price Target: $19
Current: $18.01
Upside: +5.50%
Initiates: Outperform
Price Target: n/a
Current: $97.74
Upside: -
Downgrades: Peer Perform
Price Target: n/a
Current: $33.23
Upside: -
Initiates: Outperform
Price Target: n/a
Current: $516.69
Upside: -
Initiates: Outperform
Price Target: n/a
Current: $13.61
Upside: -
Upgrades: Outperform
Price Target: n/a
Current: $71.78
Upside: -
Initiates: Peer Perform
Price Target: n/a
Current: $52.06
Upside: -
Initiates: Outperform
Price Target: $17
Current: $27.77
Upside: -38.78%
Initiates: Outperform
Price Target: $42
Current: $134.94
Upside: -68.88%